RCG
Rock Creek Group’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,636
| Closed | -$153K | – | 83 |
|
|
2023
Q3 | $153K | Sell |
2,636
-627
| -19% | -$36.4K | 0.02% | 96 |
|
|
2023
Q2 | $209K | Buy |
3,263
+142
| +5% | +$9.08K | 0.03% | 91 |
|
|
2023
Q1 | $216K | Sell |
3,121
-66
| -2% | -$4.57K | 0.03% | 90 |
|
|
2022
Q4 | $229K | Sell |
3,187
-776
| -20% | -$55.8K | 0.03% | 81 |
|
|
2022
Q3 | $282K | Sell |
3,963
-1,737
| -30% | -$124K | 0.04% | 80 |
|
|
2022
Q2 | $439K | Buy |
5,700
+1,335
| +31% | +$103K | 0.05% | 66 |
|
|
2022
Q1 | $319K | Buy |
4,365
+1,316
| +43% | +$96.2K | 0.04% | 80 |
|
|
2021
Q4 | $190K | Sell |
3,049
-122
| -4% | -$7.6K | 0.03% | 141 |
|
|
2021
Q3 | $188K | Sell |
3,171
-1,896
| -37% | -$112K | 0.03% | 109 |
|
|
2021
Q2 | $339K | Buy |
5,067
+984
| +24% | +$65.8K | 0.05% | 117 |
|
|
2021
Q1 | $258K | Sell |
4,083
-5,956
| -59% | -$376K | 0.04% | 108 |
|
|
2020
Q4 | $623K | Sell |
10,039
-2,413
| -19% | -$150K | 0.26% | 77 |
|
|
2020
Q3 | $751K | Sell |
12,452
-20,840
| -63% | -$1.26M | 0.39% | 67 |
|
|
2020
Q2 | $1.96M | Sell |
33,292
-4,811
| -13% | -$283K | 1.04% | 16 |
|
|
2020
Q1 | $2.12M | Buy |
38,103
+19,645
| +106% | +$1.1M | 1.17% | 21 |
|
|
2019
Q4 | $1.18M | Sell |
18,458
-899
| -5% | -$57.3K | 0.47% | 54 |
|
|
2019
Q3 | $982K | Buy |
19,357
+166
| +0.9% | +$8.42K | 0.47% | 57 |
|
|
2019
Q2 | $870K | Buy |
19,191
+6,711
| +54% | +$304K | 0.4% | 55 |
|
|
2019
Q1 | $595K | Buy |
+12,480
| New | +$595K | 0.27% | 59 |
|